Democritus University of Thrace (DUTH)
Δείκτες επάρκειας σιδήρου σε ασθενείς με τελικό στάδιο της χρόνιας νεφρικής ανεπάρκειας
Abstract
dc:descriptionIron deficiency constitutes a significant cause of anemia in hemodialysis patients and is the most common cause of resistance to erythropoietin treatment. Iron deficiency in dialysis patients is multifactorial and may be related to depletion of iron stores by chronic blood loss (absolute iron deficiency) or by an increased demand due to enhanced rate of erythropoiesis induced by erythropoietin. The latter condition is called “functional” iron deficiency and occurs because bone marrow is unable to optimally access even fairly normal iron stores under intense stimulus to produce new red blood cells. The most frequent markers to assess iron status are serum ferritin and transferrin saturation (Tsat). However, the diagnostic value of ferritin and Tsat remains controversial as their levels are influenced by inflammation and malnutrition, conditions that co-exist very frequently in dialysis patients irrespective of iron stores. Alternative markers of iron adequacy are the soluble transferrin receptor (sTfR), which increases in iron deficiency but is not influenced by inflammation procedures, the percentage of hypochromic erythrocytes (HYPO%), which rises quite early in iron deficiency, and the reticulocyte hemoglobin content (CHr) and concentration (CHCMr), which both provide “realtime” assessment of the functional state of the erythropoietic marrow. The aim of this study was the comparison of conventional and alternative markers of iron adequacy in hemodialysis patients, the correlations between them and other factors influencing erythropoiesis, the description of their changes after iron loading and the evaluation of their diagnostic value. In this study 98 stable-state haemodialysis patients were included. All patients were on stable rHuEPO maintenance dose and had no transfusions or per os/parenteral iron administration for at least 2 months. There were 52 men (53%), their mean age was 65 years and the mean duration of hemodialysis was 62 months. Detailed medical history and routine hematological and biochemical analysis, along with iron markers (ferritin, Tsat, sTfR, HYPO%, CHr, CHCMr) were reported at baseline. Each patient received 1000mg iron sucrose intravenously, distributed among 10 consecutive dialysis treatments. A response to intravenous iron was defined as an increase in hemoglobin value equal or greater than 10% from baseline values, detected at least in two recordings, during two months following the end of iron loading. The duration of the study was 14 weeks and hematological and biochemical tests were repeated regularly.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsiatsiou, Maria
- Τσιάτσιου, Μαρία
Subjects
dc:subject × 20- Σίδηρος
- Σιδηροπενία
- Αναιμία
- Δείκτες επάρκειας σιδήρου
- Χρόνια νεφρική ανεπάρκεια (ΧΝΑ)
- Αιμοκάθαρση
- Δικτυοερυθροκυτταρικοί δείκτες
- Διαλυτός υποδοχέας τρανσφερρίνης
- Iron
- Iron deficiency
- Anemia
- Iron indices
- Chronic renal failure (CRF)
- Hemodialysis
- Reticulocyte indices
- Soluble transferrin receptors (STER)
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18017